Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2025-12-27 @ 4:19 AM
Study NCT ID:
NCT02188368
Status:
TERMINATED
Last Update Posted:
2023-11-03
First Post:
2014-07-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple Myeloma Patients
Sponsor:
Oncotherapeutics
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-23
Completion Date Type:
ACTUAL
First Submit Date:
2014-07-07
First Submit QC Date:
None
Study First Post Date:
2014-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-01
Last Update Post Date:
2023-11-03
Last Update Post Date Type:
ACTUAL